SHELBY MAKRIS: Open Payments
NPI 1316535636 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,909 in 142 payments from 36 companies in 2025. Trend: 2023 $2,941 · 2024 $3,071 · 2025 $3,909
Food & beverage: $3,395Education: $513
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 12 | $370 |
| AstraZeneca Pharmaceuticals LP | 11 | $297 |
| Janssen Biotech, Inc. | 9 | $270 |
| Novartis Pharmaceuticals Corporation | 11 | $258 |
| Gilead Sciences, Inc. | 9 | $235 |
| Regeneron Healthcare Solutions, Inc. | 4 | $235 |
| ABBVIE INC. | 12 | $188 |
| Incyte Corporation | 6 | $177 |
| Astellas Pharma US Inc | 4 | $163 |
| Merck Sharp & Dohme LLC | 6 | $153 |
Products named: Enhertu, Trodelvy, LIBTAYO, KISQALI, DATROWAY, MI CANCER SEEK, Epkinly, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
